Pneumocystis Pneumonia in Human Immunodeficiency Virus-infected Adults and Adolescents: Current Concepts and Future Directions

Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Sadatomo Tasaka

Abstract

Pneumocystis jirovecii pneumonia (PCP) is one of the most common opportunistic infections in human immunodeficiency virus-infected adults. Colonization of Pneumocystis is highly prevalent among the general population and could be associated with the transmission and development of PCP in immunocompromised individuals. Although the microscopic demonstration of the organisms in respiratory specimens is still the golden standard of its diagnosis, polymerase chain reaction has been shown to have a high sensitivity, detecting Pneumocystis DNA in induced sputum or oropharyngeal wash. Serum β-D-glucan is useful as an adjunctive tool for the diagnosis of PCP. High-resolution computed tomography, which typically shows diffuse ground-glass opacities, is informative for the evaluation of immunocompromised patients with suspected PCP and normal chest radiography. Trimethoprim-sulfamethoxazole (TMP-SMX) is the first-line agent for the treatment of mild to severe PCP, although it is often complicated with various side effects. Since TMP-SMX is widely used for the prophylaxis, the putative drug resistance is an emerging concern.

References

Feb 1, 1990·The Journal of Infectious Diseases·S L PeglowP D Walzer
Jun 1, 1990·Radiology·J E KuhlmanS S Siegelman
Mar 10, 1988·The New England Journal of Medicine·J A KovacsJ E Parrillo
Apr 1, 1995·American Journal of Respiratory and Critical Care Medicine·T L BenfieldJ D Lundgren
Jan 1, 1993·Ryōikibetsu shōkōgun shirīzu·T Mitsuma
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·L HuangP C Hopewell
Sep 1, 1993·Chest·K WassermannG R Krueger
Mar 15, 1996·Annals of Internal Medicine·J H ShelhamerF P Ognibene
Jul 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A Bartlett, C Hulette
May 23, 1998·Journal of Clinical Microbiology·A M CaliendoM J Ferraro
Jun 13, 1998·Antimicrobial Agents and Chemotherapy·J A Fishman
May 5, 1999·AJR. American Journal of Roentgenology·P M BoiselleM A Kaplan
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·E AzoulayC Mayaud
Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R VassalloA H Limper
Feb 22, 2001·The Journal of Infectious Diseases·P KazanjianS R Meshnick
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HagmannH Pollack
Oct 2, 2001·AIDS·J E KaplanUNKNOWN Adult and Adolescent Spectrum of HIV Disease Project Investigators
Feb 5, 2002·Microbes and Infection·Alison MorrisLaurence Huang
Jan 23, 2004·The Journal of Eukaryotic Microbiology·Laurence HuangCharles B Beard
Oct 27, 2004·Emerging Infectious Diseases·Laurence HuangJannik Helweg-Larsen
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Aimable NahimanaPhilippe M Hauser
Feb 25, 2005·AJR. American Journal of Roentgenology·Edson MarchioriTomás Franquet
Aug 3, 2005·FEMS Immunology and Medical Microbiology·Isabelle Durand-JolyEduardo Dei-Cas

❮ Previous
Next ❯

Citations

Mar 13, 2019·British Journal of Hospital Medicine·Aline WilsonNikolas Rae
Mar 23, 2018·Journal of Fungi·Rukumani Devi VelayuthanDavid W Denning
Jan 29, 2021·Journal of Clinical Microbiology·Sean X ZhangUNKNOWN Fungal Diagnostics Laboratories Consortium (FDLC)

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
bronchoalveolar lavage
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.